Market access and value propositions

Cell and gene therapies do not fit existing frameworks for valuing, pricing, and reimbursing pharmaceuticals. In this section, Parexel experts discuss how a focus on communicating value and aligning regulatory, clinical, and market access strategies early in development could impact patient access and market success.

Download the Executive Summary